Ziagen
RxNorm concept 221017, brand name (bn).
- RxCUI
- 221017
- Term type
- Brand name (BN)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/221017 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- abacavir 300 MG Oral Tablet [Ziagen] (SBD, ingredient of)
- abacavir 20 MG/ML Oral Solution [Ziagen] (SBD, ingredient of)
- abacavir Oral Solution [Ziagen] (SBDF, ingredient of)
- abacavir Oral Tablet [Ziagen] (SBDF, ingredient of)
- abacavir 300 MG [Ziagen] (SBDC, ingredient of)
- abacavir 20 MG/ML [Ziagen] (SBDC, ingredient of)
- Ziagen Oral Liquid Product (SBDG, ingredient of)
- Ziagen Oral Product (SBDG, ingredient of)
- Ziagen Pill (SBDG, ingredient of)
- abacavir (IN, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 221017 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/221017 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 221017. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.